This analysis also pointed to the higher expression of several other genes normally deregulated in a wide spectrum of leukaemias, including genes that act as transcriptional regulators (PRDM16 and NFIX) and a gene that influences proliferative advantage and survival (IGFBP2). This evidence concerns the gene PRDM16 and leukemia.